This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis
Journal of Hematology & Oncology Open Access 08 April 2015
-
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
BMC Hematology Open Access 18 November 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Andersen MK, Pedersen-Bjergaard J, Kjeldsen L, Dufva IH, Brondum-Nielsen K . Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterised by trisomy 8. Leukemia 2002; 16: 1390–1393.
Socie G, Deeg JC . Malignancies after haematopoietic stem cell transplantation. Many questions, some answers. Blood 1998; 91: 1833–1844.
Braziel RM, Launder TM, Druker B, Olson SB, Magenis RE, Mauro MJ et al. Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience. Blood 2002; 100: 435–441.
Meeus P, Demuynck H, Martiat PH, Michaux L, Wouters E, Hagemeijer A . Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib. Leukaemia 2003; 17: 465–467.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chee, Y., Vickers, M., Stevenson, D. et al. Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones. Leukemia 17, 634–635 (2003). https://doi.org/10.1038/sj.leu.2402842
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402842
This article is cited by
-
Philadelphia chromosome-negative acute promyelocytic leukemia manifesting after long-term imatinib treatment for chronic myeloid leukemia: a case report and literature review
Annals of Hematology (2018)
-
Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis
Journal of Hematology & Oncology (2015)
-
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
BMC Hematology (2010)
-
Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors
International Journal of Hematology (2009)
-
Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL
Leukemia (2006)